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Focused Question: 
What evidence exists (published between 1988 and 
2008) on the treatment of spinal cord injury related 
spasticity with Botulinum-Toxin and Transcutaneous 
Electrical Nerve Stimulation? 
             
 
Clinical Scenario 
Roughly 70% of those experiencing a spinal cord injury are spastic 1 year after 
their injury (Kirshblum, 1999). The increase in tone for many interferes with 
functional activities of daily living (grooming, hygiene, and self-care skills), sleep, 
self-esteem, mood, and sexual function.  In some cases the spasticity can cause 
pain (Marciniak, Rader, & Gagnon, 2008).  Many different treatments exist to 
address problematic spasticity, including rehabilitation modalities (cold, electrical 
stimulation, etc), pharmacological (Diazepam, Dantrolene, Clonidine, Tizanidine), 
injection techniques (peripheral nerve block, botulinum toxin), surgery 
(Rhizotomy, nerve cuts), stretching, and splinting.  
 
Possible clients that would benefit from this treatment, according to this research, 
might be men and women who have sustained a spinal cord injury and are 
experiencing the secondary effect of spasticity in the upper or lower extremities 
or even in muscles that control bowel and bladder functions.  Years since injury 
do not seem to make a significant difference in both treatment approaches 
(electrical stimulation or botulinum toxin injections). 
 
 Occupational therapists are interested in knowing what evidence 
exists that supports using botulinum toxin injections versus transcutaneous 
electrical nerve stimulation (TENS) to treat spinal cord injury related spasticity. 
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Summary of key findings 
Summary of Levels I, II, III 
     Of the four Level I-III studies that examined the treatment of spasticity to 
improve participation in areas of occupation, one (MacDonald, Fink, Huckabay, 
Monga, & Wilt, 2007) looked at the treatment of Neurogenic detrusor overactivity 
with botulinum toxin injections, one (Richardson, et al., 2000) looked at the 
treatment of focal spasticity with botulinum toxin injections to improve passive 
movement, one (Skold, et al., 2002) examined the effects of functional electrical 
stimulation training for treating spasticity, and finally (Ji-sheng, Xiao-hong, Yu, 
Sheng-cheg, 1994) studied the effects of transcuatenous electrical nerve 
stimulation in treating spasticity.  The key findings, with subfindings, follow. 
 
• In a systematic review (MacDonald, et al., 2007), botulinum toxin (BTX-A 
and BTX-B) injections resulted in significant decreased number of Urinary 
Incontinence (UI) episodes compared to placebo, RTX, and a lower dose 
of BTX-A injections.  All subjects who received BTX-A or BTX-B injections 
had at least 1 free week of UI episodes.  The effects were lost between 24 
weeks and 18 months.  
                    1.  Adverse effects were mild and minimal (only 5 subject reports 
           out of 104 participants) 
         2.  One study reported significant improvements in 5 out of 9 
domains on the King’s Health Questionnaire of quality of life. 
• In a well controlled level I study (Richardson, et al., 2000), the group that 
received BTX-A injections had significantly better Ashworth Scale scores, 
improved Motor Function/Rivermead scores for the lower limb group, 
decrease in problem severity, and increased goal attainment. 
          1.  Even though the upper limb group did not produce significant 
scores, 3 of the 27subjects who received injections reported a return to 
work due to improved hand function, meaning there was a note-worthy 
functional improvement for some. 
          2.  They concluded that BTX-A reduces tone and increases ROM  
which may lead to improvement in focal disability within a rehab program.  
This is significant findings for occupational therapists.   
• In a cohort study (Skold, et al., 2002), functional electrical stimulation 
(FES) was performed for 30 minute sessions 3 times weekly for 6 months. 
   1.  Muscle tissue volume increased in the training group by 10% 
                     2.  Decrease in Modified Ashworth Scores for 6 months, but not in   
           subject rating of spasticity level 
                     3.  Overall, no conclusive results were provided for the treatment of 
          spasticity with FES 
• In a before and after study (Ji-sheng, et al., 1994), high frequency (100Hz) 
transcutaneous electrical nerve stimulation for 30 minutes a day for 3 
months was effective in relieving muscle spasticity 
                     1.  Decrease in Modified Ashworth Scores, lasting only 10 minutes  
           each day; the therapeutic effects became consolidated after consecutive  
           daily treatments for 3 months 
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                     2. They concluded that TENS is non-invasive and comes with little  
           to no side effects  
 
Summary of Levels IV, V 
     Of the two Level IV & V studies, one (Lockley & Freeman, 2005) examined 
the effect of a multi-disciplinary approach (including BTX-A injections) in treating 
a patient with spinal cord injury related spasticity, and one (Kirshblum, 1999) 
reviewed literature on different treatment options in addressing spinal cord injury 
related spasticity.  Both studies suggest interventions that can be experimented 
with on similar patients.  The Level IV study (Lockley & Freeman, 2005) 
describes its treatment in detail, as the literature review briefly describes different 
treatment option protocols to inquire further into if interested.  Through both 
studies, it is proposed that careful observation of change seen in the patients will 
allow the practitioner to determine continuation or discontinuation of the 
experimental treatment.   
 
• In a case report (Lockley & Freeman, 2005), tested the effectiveness of a 
program that combined BTX-A injections and rehabilitation in treating a 
woman who was unable to carry out her daily standing and walking 
program, which further inhibited her ability to perform some of her daily 
activities.  The program included goal setting, identifying factors that 
triggered her spasms, a self-management home program including 
problem solving techniques, and two rounds of BTX-A injections.  At 
follow-up, 20 months after the start of the program, her goals were fully 
achieved, the Ashworth Scale score was zero, her spasm pain scale was 
0/10, and her frequency score was 1/4.  
                  1.  Clinical importance: re-evaluation of progress using patient  
          feedback and relevant/objective outcome measures and goals, close  
          partnership between patient and therapist, strong emphasis on patient  
          education, self-management over the long-term, and focus on the patient’s 
          goals vs. medical impairment issues. 
                     2.  The direct effect of BTX-A injections lasted about three to four 
          months, but the patient experienced continued reduction in resting tone  
          without the side effects of “weakness” when standing or walking. 
• In a literature review (Kirshblum, 1999), many treatment alternatives for 
spinal cord injury related spasticity were reviewed, including TENS and 
BTX-A injections.   
                     1.  TENS applied to dermatome associated with the spastic muscle 
         was shown to have a 2 hour duration effect and a decrease on the Modified 
         Ashworth Scale. 
                     2.  BTX-A effects were shown to peak at 2-6 weeks and lasts for 3-5 
         months; improvements in nursing care, hygiene, patient comfort (decrease 
         in pain), and functional activity; drawback reported include cost and waiting 
         of a few days to see results 
                     3.  Overall study conclusion is that none of the detailed treatments  
         in the study are exceptional. 
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Bottom line for occupational therapy practice 
Occupational therapists are mainly concerned that their patients can live their life 
as independent as possible, doing the meaningful activities that they desire to do.  
In our spinal cord injured patients, spasticity can be a problematic secondary 
effect that makes it difficult for them to participate fully in life.  Research on the 
treatment of spasticity is so important for occupational therapists to know about 
in order to be an advocate for delivering the best treatment for our clients.   
 
The interventions that were tested and found beneficial in the Level I-III studies 
reviewed here include using botulinum toxin injections and transcutaneous 
electrical nerve stimulation to address problematic spasticity.  Occupational 
therapists can be involved in referring clients to receive BTX-A injections or be 
administers of TENS.  Occupational therapists can assure their patients that 
these interventions have been tested and found successful in improving 
participation with some patients. One study suggested the importance of rehab 
therapies in conjunction with BTX-A injection treatments (Richardson, 2000).  
Overall, the four Level I-III studies have pointed towards BTX-A injections being 
the most effective in treating spinal cord injury related spasticity.  The injections 
have a longer lasting effect and minimal adverse effects.  TENS can be useful for 
some patients, and is non-invasive, but has a much shorter duration, requiring 
more treatments.  
 
The experimental case report writers described the multi-disciplinary treatment, 
including BTX-A injections, in detail, but the literature review had inconclusive 
findings. 
 
The ideal intervention for the treatment of spinal cord injury related spasticity is 
still unknown. Further research needs to be completed.   
 
Review process: 
• Titles of those studies retrieved by online database searches were 
reviewed 
• Abstracts of those studies whose titles addressed the topic were reviewed 
• Abstracts were read and those studies that did not address the question or 
did not meet inclusion criteria were not used 
• The remaining studies (N=6) were retrieved either from Pacific University 
library system, interlibrary loan (Illiad), online sources, personal collection 
• Studies that were published before 1994 were eliminated (N=1) 
• Each study was read and those not meeting inclusion criteria were further 
deleted (N=4 ) 
• Each of the remaining studies was analyzed and the evidence table was 
completed.  For this question, six studies were analyzed 
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Inclusion criteria 
• Published between 1994 and 2008  
• All levels of evidence, including case reports (Level V), were located and 
reviewed 
• Majority of participants were persons with spinal cord injury 
• Participants were adults (> 18 years) 
• Written in English 
 
 
Exclusion criteria 
• Longitudinal observational studies of natural history of recovery 
• Descriptions of programs or of treatments without testing effects 
• Written before 1994 
• If majority of participants did not have spinal cord injury (i.e. stroke, MS) 
 
Search strategy 
Categories Key search terms 
Patient/client population Spinal cord injury(ies) 
Intervention Botulinum toxin, trascutaneous 
electrical nerve stimulation, functional 
electrical stimulation, spasticity and 
TENS, spasticity and SCI, treatment 
alternatives and SCI, muscle spasticity 
and Transcutaneous electrical nerve 
stimulation and SCI, muscle spasticity 
and Botulinum Toxin and SCI, 
botulinum toxin and transcuatenous 
electrical nerve stimulation 
Comparison Systematic reviews, randomized 
control trials, meta-analysis, case 
report 
Outcome Decrease spasticity 
 
Audit trail 
• The only limit used while researching for studies: peer-reviewed 
• Limits used for selecting articles for reviewing: I am not an experienced 
researcher, search was thorough but not exhaustive, also see 
inclusion/exclusion criteria 
Databases Terms Retrieved Reviewed Used 
Cochrane Botulinum toxin & Spinal Cord Injury (SCI) 
TENS & SCI 
Transcutaneous electrical nerve stimulation 
(TENS) & SCI 
Spasticity & SCI 
Spasticity & TENS 
 
 
 
 
8 
2 
 
 
 
 
2 
1 
 
 
 
 
1 
0 
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Treatment alternatives & SCI 4 1 1 
CINAHL Muscle spasticity & TENS &SCI 
Muscle spasticity & botulinum toxin & SCI 
Botulinum toxin & TENS 
89 
10 
2 
2 
1 
1 
Medline Systematic review & botulinum toxin & SCI 
Systematic review & TENS & SCI 
Case report & SCI 
5 
0 
6 
1 
 
1 
1 
 
1 
Class handout Spasticity & SCI 1 1 0 
Personal 
AJOT 
OT & botulinum toxin 1 1 0 
 
Quality control/Peer review process 
Only the author reviewed these articles.  The studies were read twice and 
reviewed further when questions arose. 
 
Results of search: 
Summary of study designs of articles selected for appraisal 
Level of evidence Study design/ 
methodology of 
selected articles 
Number of articles 
selected 
I Systematic reviews, 
meta-analysis, 
randomized controlled 
trials 
2 
II Cohort, case control 1 
III Before and after 1 
IV Single subject, case 
series 
1 
V Case report, expert 
opinion (lit review) 
1 
 Qualitative studies 0 
  Total: 6 
 
Limitations of studies appraised: 
Levels I, II, III 
Level I 
Heterogeneity of the sample and the inability for the researchers to control the 
rehabilitation that the participants were receiving before their inclusions in the 
trial (Richardson, et al., 2000) 
Level II 
Small sample size, incomplete information on how participants were recruited 
and no clear clinical importance (Skold, et al., 2002) 
Level III 
Inadequate information on participant recruitment and data collection process; 
absence of control group (Ji-sheng, et al., 1994) 
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Levels IV, V 
Level IV 
No controls for intervening variables; no statistical analyses; inability to 
generalize the results 
Level V 
Minimal information on participants from the various treatment studies reviewed; 
no controls for intervening variables; no statistical analyses 
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